Should You Buy Repligen Corporation (RGEN) in Medical Instruments & Supplies Industry?

Repligen Corporation (RGEN) is near the top in its industry group according to InvestorsObserver. RGEN gets an overall rating of 56. That means it scores higher than 56 percent of stocks. Repligen Corporation gets a 70 rank in the Medical Instruments & Supplies industry. Medical Instruments & Supplies is number 64 out of 148 industries.

RGEN has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on RGEN!

See Full RGEN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 56 means the stock is more attractive than 56 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Repligen Corporation Stock Today?

Repligen Corporation (RGEN) stock is trading at $295.99 as of 3:15 PM on Wednesday, Sep 15, an increase of $1.49, or 0.51% from the previous closing price of $294.50. Volume today is 249,610 compared to average volume of 258,139. The stock has traded between $294.29 and $299.74 so far today. Click Here to get the full Stock Report for Repligen Corporation stock.